Moneycontrol » News » Stocks » Brokerage Recommendations

Hold Dishman Pharma, tgt of Rs 323: India Capital Markets

Published on Fri, Oct 03, 2008 at 16:52 |  Source : Moneycontrol.com

Updated at Fri, Oct 03, 2008 at 16:55  

6329 Investors following Dishman Pharma. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

ALSO READ

Dishman Pharma

BSE | NSE 10/02/12

India Capital Markets has recommended a hold rating on Dishman Pharmaceuticals & Chemicals with a target of Rs 323 in its September 29, 2008 research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment......

Attachments : CRAMS_ICMPL.pdf

  

PREVIOUS STORY

RBC cautiously confident of solution on EU crisis shortly

NEXT STORY

Buy Ashok Leyland; target of Rs 32: Angel Broking

More on Moneycontrol
Headlines
view all »
S&P downgrades 34 Italian banks
01:36 AM
S&P downgrades 34 Italian banks
The week that was: Deal or no deal, mkt in for taxing times
07:47 PM
The week that was: Deal or no deal, mkt in for taxing times
Know Your Investment: Expert takes 'stock' of your stocks!
08:36 PM
Know Your Investment: Expert takes 'stock' of your stocks!
Wall St week ahead: Bulls won't be tamed by weak earnings
04:52 AM
Wall St week ahead: Bulls won't be tamed by weak earnings
Video of the day
'5200 strong support for mkt, next resistance at 5500-5550'
play
09:56 AM
'5200 strong support for mkt, next resistance at 5500-5550'
- in FII View
Sensex logs 6th week of gain, ends day with 85 pts loss
Listen Now!
Slideshows

Trending News

Business News

Tags: India Capital Markets, Dishman Pharmaceuticals & Chemicals, recommendation
No entry fee to migrate to Unified License, proposes TRAI
Rupee rally may stall with fall against US dollar, euro "Rupee rally may stall with fall against US dollar, euro"

News

Sources Say 'Meet To Decide If Govt Should Move Leave Plea On SC Order'

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com

Explore Moneycontrol

STOCKS     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
MUTUAL FUNDS     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News | Markets | IPO | Technicals | Mutual Fund | Commodities | Best Portfolio Manager | Bse Sensex | Bombay Stock Exchange | Share Market Live | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | National Stock Exchange | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds | Unit Linked Insurance Plans (ULIPs) | | Budget: 2008, 2009, 2010, 2011, 2012 |  Intuit Money Manager | RBI Credit Policy | Union Budget | Budget 2012  | Economic Survey  | Railway Budget  | Financial Glossary  |  Message Board | Moneybhai | Connect.in.com | Business Yellow Pages | India's Premiere Technology Guide | History India  | Up Polls |  Latest News  | Uninor | Tata Steel | BSE Sensex | Commodities | Aurobindo Pharma | Namma Metro | Mahindra Satyam | Iran | Reliance Industries | Vodafone Essar
Site Map  |  About Us  |  Contact Us  |  Advertise  |  Bookmark  |  Disclaimer  |  Privacy Statement  |  Terms of Use  |  Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.